Recombinant Chromobacterium violaceum Adenylosuccinate synthetase 2 (purA2)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested and agreed upon in advance (incurring additional charges).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, but this can be adjusted to suit your needs.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its implementation.
Synonyms
purA2; CV_3528; Adenylosuccinate synthetase 2; AMPSase 2; AdSS 2; EC 6.3.4.4; IMP--aspartate ligase 2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-431
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Chromobacterium violaceum (strain ATCC 12472 / DSM 30191 / JCM 1249 / NBRC 12614 / NCIMB 9131 / NCTC 9757)
Target Names
purA2
Target Protein Sequence
MSKNVVVIGT QWGDEGKGKI VDWLTDHARA VVRFQGGHNA GHTLWVNGKK TVVRLVPSGI LRPDVECFIG NGVVLSPEAL LKEIDELEAA GVNASARLKI AEGCPLILPY HIALDQAREA AKGDAKIGTT GRGIGPCYED KVARRALKVI DLFDPARFET KLKENVDYYN FLLTNLFKAE PVSYEAILAD TMKMAERIKP MVADVSRTLY DLDKAGTPIL FEGAQGTLLD IDHGTYPYVT SSNCVAGAAA PGAGVPPQML NYVLGIVKGY ATRVGSGPFP TEQENEIGAF LAKRGNEFGS VTGRPRRCGW FDAAALKRSI QINGVSGLCV MKLDVMDGLE EIKLCTGYML DGQKVDILPF GSDAVTKCEP VYETLPGWTG TTVGVKRWED LPANAQAYLK RIEEVCGAPV DIVSTGPDRE ETIVLRHPFG L
Uniprot No.

Target Background

Function
This protein plays a crucial role in the de novo purine nucleotide biosynthesis pathway. It catalyzes the initial committed step in AMP biosynthesis from IMP.
Database Links

KEGG: cvi:CV_3528

STRING: 243365.CV_3528

Protein Families
Adenylosuccinate synthetase family
Subcellular Location
Cytoplasm.

Q&A

How can I express and purify recombinant C. violaceum purA2 for research purposes?

Expression and purification of recombinant C. violaceum purA2 requires a systematic approach:

Expression Protocol:

  • Gene acquisition: Amplify the purA2 gene from C. violaceum strain ATCC 12472 genomic DNA using PCR

  • Vector construction: Clone the gene into an expression vector with an N-terminal His-tag

  • Expression system: Transform into a prokaryotic expression system (E. coli) or use a mammalian cell expression system for potentially better folding

  • Induction: Optimize induction conditions (temperature, inducer concentration, duration)

How should I design experimental assays to measure purA2 enzymatic activity?

Designing robust enzymatic assays for purA2 requires careful consideration of reaction conditions and appropriate controls:

Standard Assay Components:

  • Buffer: Tris-HCl or phosphate buffer (pH 7.0-7.5)

  • Substrates: IMP, GTP, and aspartate at optimized concentrations

  • Cofactors: Mg²⁺ (essential for catalytic activity)

  • Enzyme concentration: Use amount that gives linear activity over time

Activity Measurement Methods:

  • Spectrophotometric assay: Monitor the increase in absorbance at 280 nm due to AMP formation

  • Coupled enzyme assay: Link AMP production to NADH oxidation using auxiliary enzymes

  • Radioactive assay: Use ¹⁴C-labeled aspartate and measure incorporation into adenylosuccinate

Control Experiments:

  • Positive controls: Known active adenylosuccinate synthetase (commercial source)

  • Negative controls:

    • Heat-inactivated enzyme

    • Reaction mixture without enzyme

    • Reaction mixture minus individual substrates

  • Specificity controls: Related enzymes to test assay specificity

This approach is similar to standard enzyme assays described for other enzymes in the literature , though specific optimizations for purA2 may be necessary.

How does C. violaceum purA2 structure compare to adenylosuccinate synthetases from other organisms?

The structure of C. violaceum purA2 shares fundamental features with other adenylosuccinate synthetases while maintaining species-specific characteristics:

Key Differences:

Recent comparative analyses of adenylosuccinate synthetases reveal specific residues that may differentiate bacterial and human enzymes. While the search results don't provide a direct structural comparison of C. violaceum purA2, other studies on Pur proteins indicate that mutations in key residues like arginine can significantly impact nucleic acid binding and enzymatic function .

From crystallographic studies of related enzymes, we know that the Whirly-like fold with three beta sheets and an alpha helix in the configuration N-βββα-C is critical for function .

Future research directly comparing the crystal structure of C. violaceum purA2 with human ADSS2 would provide valuable insights for drug design efforts targeting the bacterial enzyme specifically.

What is the relationship between purA2 and C. violaceum pathogenicity?

While purA2 is not directly classified as a virulence factor like the Type III Secretion Systems (T3SSs) in C. violaceum, it plays an important supportive role in pathogenicity:

Metabolic Contribution to Virulence:

  • Nutrient acquisition: purA2 enables de novo purine synthesis, allowing the bacterium to grow in host environments where purines may be limited

  • Growth support: As a key metabolic enzyme, purA2 supports bacterial replication during infection

  • Adaptation: Facilitates bacterial adaptation to changing host environments

Context in C. violaceum Virulence:

C. violaceum's high virulence in human infections and mouse infection models primarily involves several other virulence factors, particularly two Type III Secretion Systems (T3SSs). The T3SS designated Cpi-1 plays a pivotal role in host cell interactions and is required for the secretion of effector proteins .

How should I design inhibition studies targeting C. violaceum purA2?

Designing effective inhibition studies for purA2 requires a structured approach:

Inhibitor Screening Strategy:

  • Initial screening: Test compounds at a fixed concentration (e.g., 100 μM) to identify hits

  • Dose-response analysis: For promising compounds, determine IC50 values using 6-8 concentrations

  • Mechanism studies: Determine inhibition type (competitive, non-competitive, uncompetitive)

  • Selectivity assays: Compare inhibition against human ADSS2 to assess specificity

Experimental Design Table:

Experiment TypePurposeKey MeasurementsAnalysis Method
Initial screeningIdentify potential inhibitors% inhibition at fixed concentrationZ-score, hit threshold
Dose-responseDetermine potencyActivity at multiple inhibitor concentrationsNon-linear regression, IC50 calculation
Mechanism studiesElucidate inhibition typeActivity at varying substrate and inhibitor concentrationsLineweaver-Burk, Dixon plots
SelectivityAssess specificityIC50 against both bacterial and human enzymesSelectivity index (SI) calculation

Statistical Analysis:

  • Use non-linear regression to fit dose-response curves

  • Calculate 95% confidence intervals for IC50 values

  • Apply appropriate statistical tests (ANOVA, t-tests) to compare inhibitors

  • Include at least three technical replicates per condition

This approach follows standard enzyme inhibition study methods while focusing specifically on features relevant to purA2 as a potential antimicrobial target.

Potential Regulatory Mechanisms:

  • Quorum sensing: C. violaceum uses N-hexanoyl-L-homoserine lactone (HHL) to regulate various phenotypic characteristics including production of violacein, hydrogen cyanide, antibiotics, and exoproteases . While not directly linked to purA2 regulation, quorum sensing could potentially influence purine metabolism.

  • Metabolic regulation: Being part of the purine biosynthesis pathway, purA2 expression is likely regulated by purine availability through feedback mechanisms.

  • Environmental adaptation: C. violaceum has demonstrated ability to adapt to various environmental conditions, including soil and water habitats , suggesting regulatory systems responsive to environmental cues.

Research Approach to Study purA2 Regulation:

To investigate purA2 regulation, researchers could:

  • Analyze purA2 promoter regions for regulatory elements

  • Measure purA2 expression under different growth conditions

  • Investigate the impact of quorum sensing mutants on purA2 expression

  • Examine transcriptional changes in response to purine availability

These approaches would help elucidate the specific regulatory mechanisms controlling purA2 expression in C. violaceum.

How does C. violaceum's energetic metabolism relate to purA2 function?

The purA2 enzyme operates within C. violaceum's broader energetic metabolism network, with several important interconnections:

Metabolic Context of purA2:

C. violaceum utilizes various metabolic pathways, including the Embden-Meyerhoff pathway, and can synthesize all amino acids it needs . Within this metabolic network, purA2 plays a crucial role in purine biosynthesis, which is energy-intensive and connected to central carbon metabolism.

Energy-Metabolism Connections:

  • GTP utilization: The purA2 reaction consumes GTP, linking it to the cell's energy state

  • Relationship to central carbon metabolism: Purine metabolism interconnects with several central metabolic pathways

  • Aerobic conditions: Like violacein production, which only occurs under aerobic conditions , optimal purA2 function may depend on the cell's respiratory state

C. violaceum possesses unique metabolic features, including an operon for HCN synthase that transfers electrons to oxygen through the respiratory chain under low oxygen conditions . This distinctive energetic metabolism creates a specific context in which purA2 functions.

To fully understand purA2's role in C. violaceum metabolism, researchers should consider these broader metabolic networks and energy-generating systems when designing experiments and interpreting results.

What advanced analytical techniques can be used to study purA2 structure-function relationships?

Several sophisticated analytical techniques can provide valuable insights into purA2 structure-function relationships:

Structural Biology Approaches:

  • X-ray crystallography: Determine high-resolution 3D structure of purA2, with and without bound substrates or inhibitors

  • Cryo-electron microscopy (Cryo-EM): Visualize purA2 in different conformational states

  • NMR spectroscopy: Analyze protein dynamics and ligand interactions in solution

Functional Analysis Techniques:

  • Site-directed mutagenesis: Systematically alter key residues to determine their roles in catalysis

  • Isothermal titration calorimetry (ITC): Measure thermodynamic parameters of substrate binding

  • Surface plasmon resonance (SPR): Determine binding kinetics of substrates and inhibitors

Computational Methods:

  • Molecular dynamics simulations: Model protein flexibility and conformational changes

  • Quantum mechanics/molecular mechanics (QM/MM): Study reaction mechanisms at the electronic level

  • Virtual screening: Identify potential inhibitors through computational docking

The study of VioA from C. violaceum, which involved structure-based mutagenesis and enzyme kinetics to identify key catalytic residues (Arg64, Lys269, and Tyr309), provides a useful methodological template for similar studies of purA2 .

How should contradictory results in purA2 research be interpreted and resolved?

Contradictory results in enzyme research are not uncommon and require a systematic approach to resolve:

Sources of Contradictions in Enzyme Research:

  • Methodological differences: Variations in assay conditions, enzyme preparation, or detection methods

  • Enzyme source variation: Differences in expression systems or purification protocols

  • Data analysis approaches: Different kinetic models or statistical methods

  • Experimental design limitations: Inadequate controls or sample sizes

Resolution Framework:

  • Standardize experimental conditions: Use consistent buffer compositions, substrate concentrations, and temperature

  • Multi-method validation: Employ different complementary techniques to measure the same parameter

  • Collaborative verification: Engage independent laboratories to replicate key findings

  • Meta-analysis approach: Systematically analyze all available data to identify patterns

Experimental Design to Resolve Contradictions:

For example, if contradictory Km values are reported for purA2:

ApproachImplementationExpected Outcome
Condition mappingTest enzyme activity across a range of pH, temperature, and buffer conditionsIdentify condition-dependent variations in kinetic parameters
Method comparisonMeasure activity using different assay techniquesDetermine if discrepancies are method-dependent
Statistical analysisApply different fitting models to the same raw dataReveal if contradictions arise from analysis choices

Following experimental design principles outlined in research methodology resources , researchers should document all experimental conditions thoroughly and conduct appropriate statistical analyses to determine the significance of observed differences.

How does purA2 compare with other enzymes in the purine biosynthesis pathway of C. violaceum?

While the search results don't provide direct comparisons between purA2 and other purine biosynthesis enzymes in C. violaceum, we can construct a contextual analysis:

Position in Purine Biosynthesis Pathway:

purA2 catalyzes a late step in de novo purine biosynthesis, converting IMP to AMP. This positions it as a branch point enzyme that specifically directs purine synthesis toward adenine nucleotides rather than guanine nucleotides.

Comparative Analysis with Other Purine Enzymes:

Although direct comparisons are not provided in the search results, typical characteristics that would distinguish purA2 include:

  • Substrate specificity: Unlike earlier enzymes in the pathway that work on common intermediates, purA2 specifically recognizes IMP

  • Regulatory sensitivity: Branch point enzymes often show different regulatory patterns than enzymes in the main pathway trunk

  • Evolutionary conservation: The degree of sequence conservation may differ between purA2 and other pathway enzymes

Future research should specifically investigate how purA2 is coordinated with other enzymes in the pathway, potentially through metabolomics studies tracking flux through the pathway under different conditions.

What are the most effective experimental controls for purA2 enzyme assays?

Robust experimental controls are essential for reliable purA2 enzyme assays:

Essential Controls for Enzymatic Assays:

Control TypeImplementationPurpose
Activity controlsActive enzyme preparation with all substratesEstablish baseline activity
No-enzyme controlMeasure non-enzymatic background
Heat-inactivated enzymeConfirm enzymatic nature of reaction
Substrate controlsOmit individual substrates (IMP, GTP, aspartate)Verify substrate requirements
Substrate analogsTest substrate specificity
Inhibition controlsKnown inhibitorValidate assay sensitivity
Solvent control (for inhibitor studies)Control for solvent effects
Assay validationLinear range determinationEnsure measurements in linear range
Time courseVerify steady-state conditions

Implementation Strategy:

  • Include all controls in every experimental run

  • Process controls identically to experimental samples

  • Randomize the order of samples and controls

  • Blind the analysis where possible

This approach follows standard enzyme assay methodology as described in the literature, including principles demonstrated in simple enzyme experiments .

How can I analyze kinetic data from purA2 enzymatic assays?

Analyzing kinetic data from purA2 assays requires appropriate mathematical models and statistical approaches:

Kinetic Data Analysis Workflow:

  • Primary data processing:

    • Subtract background signals from all measurements

    • Convert raw signals to reaction rates

    • Check for linearity in time-dependent measurements

  • Michaelis-Menten kinetics:

    • Plot reaction velocity (v) versus substrate concentration [S]

    • Fit data to the equation: v = Vmax × [S] / (Km + [S])

    • Extract Km and Vmax parameters using non-linear regression

  • Alternative linear transformations (for verification):

    • Lineweaver-Burk plot (1/v vs 1/[S])

    • Eadie-Hofstee plot (v vs v/[S])

    • Hanes-Woolf plot ([S]/v vs [S])

  • Inhibition analysis:

    • Determine IC50 values from dose-response curves

    • Create Dixon plots (1/v vs [I]) to determine inhibition type and Ki

Statistical Considerations:

  • Calculate standard errors for all kinetic parameters

  • Use weighted regression for heteroscedastic data

  • Compare models using AIC or F-test for nested models

  • Include replicate experiments to assess reproducibility

Data Visualization:

Create clear, professionally formatted graphs following scientific conventions for enzyme kinetics data, similar to those used in mixed methods analysis research .

What role might purA2 play in C. violaceum's interactions with other organisms?

While the search results don't directly address purA2's role in interspecies interactions, we can infer potential functions based on C. violaceum's ecological context:

Potential Ecological Roles:

  • Competition with other microorganisms: Efficient purine metabolism mediated by purA2 may provide competitive advantages in nutrient-limited environments

  • Host interactions: During infection, purA2 could support growth in host environments where purines are restricted as part of nutritional immunity

  • Environmental adaptation: purA2 function may be modulated in different environmental niches

Context from C. violaceum Biology:

C. violaceum produces several compounds that mediate interactions with other organisms:

  • Violacein: The characteristic purple pigment with antimicrobial properties

  • Chitinolytic enzymes: Regulated by quorum sensing and important for interactions with chitin-containing organisms

  • Hydrogen cyanide: Potentially involved in antagonistic interactions

While purA2 is not directly linked to these interaction mechanisms in the search results, its role in supporting bacterial metabolism would indirectly contribute to the organism's ability to produce these compounds and compete in its environment.

Future research could explore how purA2 expression or activity changes during C. violaceum interactions with other microorganisms, plants, or animal hosts.

How can I design experiments to investigate potential inhibitors of purA2 as antimicrobial agents?

Designing experiments to evaluate purA2 inhibitors as potential antimicrobials requires a multi-level approach:

Experimental Design Framework:

  • Enzyme-level screening:

    • High-throughput screening of compound libraries against purified purA2

    • Confirmation of hits with dose-response curves

    • Mechanism of action studies for promising compounds

  • Cellular-level evaluation:

    • Determine minimum inhibitory concentration (MIC) against C. violaceum

    • Assess cytotoxicity against mammalian cells to establish selectivity

    • Confirm target engagement through metabolomics or resistant mutant studies

  • Validation studies:

    • Test activity against clinical isolates

    • Evaluate activity in biofilm models

    • Assess potential for resistance development

Experimental Design Table:

StageAssayMetricsSuccess Criteria
Target validationpurA2 knockout/knockdownGrowth inhibitionSignificant growth defect
Primary screeningEnzyme inhibition assay% inhibition at 10 μM>50% inhibition
Secondary screeningDose-response enzyme inhibitionIC50<1 μM
Cellular activityMIC determinationMIC<10 μg/mL
SelectivityMammalian cell cytotoxicityCC50Selectivity index >10
Mode of actionMetabolite rescueGrowth restorationRescue by adenine not other purines

This approach integrates principles of both enzyme inhibition studies and antimicrobial development, following established experimental design methodologies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.